The SARS-CoV-2 epidemic in southern Africa has been characterized by three distinct waves.
The first was associated with a mix of SARS-CoV-2 lineages, while the second and third …

Three lineages (BA.1, BA.2 and BA.3) of the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) Omicron variant of concern predominantly drove South Africa’s fourth …

Earlier variants of SARS-CoV-2 have been associated with hypercoagulability and an
extensive formation of fibrin amyloid microclots, which are considered to contribute to the …

Hepatitis B virus (HBV) infection represents a significant global health threat, accounting for
300 million chronic infections and up to 1 million deaths each year. HBV disproportionately …

A group of German visitors who had received three doses of SARS-CoV-2 vaccines, including
at least two doses of an mRNA vaccine, experienced breakthrough infections with omicron …

In sub-Saharan Africa, simple biomarkers of liver fibrosis are needed to scale-up hepatitis B
treatment. We conducted an individual participant data meta-analysis of 3,548 chronic …

South Africa’s fourth COVID-19 wave was driven predominantly by three lineages (BA.1, BA.2
and BA.3) of the SARS-CoV-2 Omicron variant of concern. We have now identified two …

Background The Global Hepatitis Health Sector Strategy is aiming for “elimination of viral
hepatitis as a public health threat” by 2030 [1], while enhanced elimination efforts for hepatitis …

The Beta variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
emerged in South Africa in late 2020 and rapidly became the dominant variant, causing over 95…

Background: Stigma, poverty, and lack of knowledge present barriers to the diagnosis and
treatment of chronic infection, especially in resource-limited settings. Chronic Hepatitis B virus …